The role of lifestyle factors on comorbidity of chronic liver disease and cardiometabolic disease in Chinese population: A prospective cohort study

[1]  Hongbing Shen,et al.  Adherence to Healthy Lifestyle and Liver cancer in Chinese: a prospective cohort study of 0.5 million people , 2021, British Journal of Cancer.

[2]  R. Clarke,et al.  Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study , 2021, European heart journal.

[3]  R. Clarke,et al.  Observational and Genetic Associations of Body Mass Index and Hepatobiliary Diseases in a Relatively Lean Chinese Population , 2020, JAMA network open.

[4]  D. Bennett,et al.  Association of physical activity with risk of hepatobiliary diseases in China: a prospective cohort study of 0.5 million people , 2020, British Journal of Sports Medicine.

[5]  Z. Younossi,et al.  Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD , 2020, Hepatology.

[6]  A. Pan,et al.  Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies , 2020, British Journal of Cancer.

[7]  T. H. Nguyen,et al.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.

[8]  E. Tsochatzis,et al.  Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach , 2020, Canadian journal of gastroenterology & hepatology.

[9]  Mohammad Hossein Khosravi,et al.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 , 2019, JAMA oncology.

[10]  S. Baumeister,et al.  Physical activity and the risk of liver cancer: a systematic review and meta-analysis of prospective studies and a bias analysis. , 2019, Journal of the National Cancer Institute.

[11]  Zhengming Chen,et al.  Central adiposity in relation to risk of liver cancer in Chinese adults: A prospective study of 0.5 million people , 2019, International journal of cancer.

[12]  R. Clarke,et al.  Adiposity in relation to risks of fatty liver, cirrhosis and liver cancer: a prospective study of 0.5 million Chinese adults , 2019, Scientific Reports.

[13]  H. El‐Serag,et al.  Epidemiology and Management of Hepatocellular Carcinoma. , 2019, Gastroenterology.

[14]  R. Clarke,et al.  Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People , 2018, Hepatology.

[15]  A. Pandey,et al.  An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. , 2018, Progress in cardiovascular diseases.

[16]  M. Kivimäki,et al.  Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study , 2018, PLoS medicine.

[17]  J. Bruix,et al.  Hepatocellular carcinoma , 2018, The Lancet.

[18]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[19]  G. D’Amico,et al.  Clinical states of cirrhosis and competing risks. , 2017, Journal of hepatology.

[20]  Herbert Tilg,et al.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases , 2017, Gut.

[21]  H. Yki-Järvinen.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. , 2014, The lancet. Diabetes & endocrinology.

[22]  T. Lash,et al.  Development and validation of a comorbidity scoring system for patients with cirrhosis. , 2014, Gastroenterology.

[23]  M. Al-mallah,et al.  A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? , 2013, Atherosclerosis.

[24]  Roy J. Shephard,et al.  2011 Compendium of Physical Activities: A Second Update of Codes and MET Values , 2012 .

[25]  R. Collins,et al.  China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.

[26]  David R Bassett,et al.  2011 Compendium of Physical Activities: a second update of codes and MET values. , 2011, Medicine and science in sports and exercise.

[27]  S. Naveau.  Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. , 2010, Gastroenterologie clinique et biologique.

[28]  V. Beral,et al.  Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study , 2010, BMJ : British Medical Journal.

[29]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[30]  Gonghuan Yang,et al.  Validation of verbal autopsy procedures for adult deaths in China. , 2006, International journal of epidemiology.

[31]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[32]  A. Hevener,et al.  IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.

[33]  H. Tilg,et al.  Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.

[34]  Marjan van den Akker,et al.  Comorbidity or multimorbidity: what's in a name ? A review of literature , 1996 .